Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. No visible changes to the study details.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the warning about lapses in government funding and potential delays in updates from the page, while the study details content remains unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedCore study content appears unchanged; the screenshots show only minor UI/layout adjustments that do not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdated page version from v3.0.2 to v3.1.0, adding new identifiers and contact emails, indicating a revision of core content and metadata.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.0.2 added; previous v3.0.1 removed. The 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.